ICPO and UroTeragLATAM signed a strategic agreement to accelerate Theranostics for urological cancer in Latin America Juan Davila, Partner Engagement & Fundraising Director, Dr. Marwa Hakkam, ...
CD25 rewires oncogene signaling in AML and ALL, revealing druggable complexes and a bold strategy: push pathways into toxic ...
Bayer today announced results from the ongoing global Phase I first-in-human, dose-escalation PAnTHa study (NCT06217822) evaluating the safety, tolerability and preliminary efficacy of ...
At the Faculty of Medicine, the Translational Research Centre in Onco-Haematology (CRTOH) brings together the leading forces in oncology research around a shared goal: to transform scientific ...
Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E Advancements in profiling technologies have deepened our ...
The therapeutic landscape for cutaneous T-cell lymphoma (CTCL) is undergoing a significant shift with the emergence of denileukin diftitox (Lymphir), the first systemic treatment ...
Transforming a nation of 1.4 billion people into the world's leading R&D hub is a monumental task. But by liberating the minds of the next generation of Indian scientists at 11, 12, and 13 years old, ...
Pomdoctor Limited ("Pomdoctor" or the "Company") , a leading online medical services platform for chronic diseases in China, today announced a strategic upgrade centered on the core track of ...
Since its inception, artificial intelligence (AI) has been developed to mimic the adaptation and self-organization of living organisms or biological ...
As the demand for specialized, high-acuity surgical care grows within the Indian subcontinent, many patients are looking ...
Bayer presents positive results from global phase I first-in-human, dose-escalation PAnTHa study at ASCO GU 2026: Berlin, Germany Monday, March 2, 2026, 13:00 Hrs [IST] Bayer anno ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results